Potentiation of catecholamines by a new diphenylalkanolamine. I. Studies in vivo and general pharmacology.
D000109:Acetylcholine / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004285:Dogs; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology*; D005260:Female; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D011748:Pyrogallol / Q000494:pharmacology; D011817:Rabbits; D012119:Respiration / Q000187:drug effects
D000605:Amino Alcohols; D006834:Hydrazines; D011748:Pyrogallol; D006632:Histamine; D007545:Isoproterenol; D000109:Acetylcholine; D009638:Norepinephrine; D004837:Epinephrine